What is MaRS EXCITE?

As part of the MaRS Health services, the MaRS Excellence in Clinical Innovation Technology Evaluation (EXCITE) program is a collaboration between a range of stakeholders in the health system that work together to help innovative health technologies get to market faster and improve patient outcomes.

At the end of the program, companies will have a robust evidence package, called the EXCITE core evidentiary bundle, that they can use for both Health Canada licensing and reimbursement and purchasing reviews.

The EXCITE Core Evidentiary Bundle includes:

  • a clinical trial/ field evaluation involving human patients that studies safety, efficacy, and clinical utility of the health technology
  • a systematic review that critically appraises relevant research and data from other studies that to understand the relative effectiveness of a technology, and how it compares with other similar technologies
  • an economic analysis that examines the cost effectiveness of the technology and potential associated cost savings to the system

Additional EXCITE offerings

Upon request, EXCITE offers the following additional programs:

  • Analysis of barriers to uptake
  • Patient preference analyses
  • Human factors and usability assessments
  • Programs to train end users
  • Longitudinal registry studies to evaluate the performance of the technology (including safety) once adopted by the health system

Beside device

  • Teresa Mattarelli joins EXCITE Management Board More...
  • Article: Limits of Cost-Effectiveness Analysis and HTA More...
  • Video: “How do we balance supply and demand of health innovations?” More...
  • EXCITE CSO Dr. Les Levin receives distinguished service award at ISPOR More...
  • THETA announces launch of SIESTA study to examine ApneaDx More...
  • EXCITE Director, Dr. Zayna Khayat speaks on the importance of raising Canada’s innovation profile at 25th CADTH symposium More...
  • MaRS EXCITE’s CSO, Dr. Les Levin and Dr. Murray Krahn win CADTH awards for excellence in HTA More...
  • EXCITE welcomes Shirlee Sharkey to the MaRS EXCITE Management Board More...
  • India government set to tighten regulation of clinical trials More...
  • MaRS welcomes Dr. Zayna Khayat as Senior Advisor, Health Systems Innovation and EXCITE Program Director More...